Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Related Articles by Review for PubMed (Select 18300814)

1.

Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies.

Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK.

Am J Surg Pathol. 2008 Mar;32(3):377-82. doi: 10.1097/PAS.0b013e3181570343.

PMID:
18300814
2.

Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.

Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E.

Eur Urol. 2010 Jul;58(1):75-83. doi: 10.1016/j.eururo.2010.03.015. Epub 2010 Mar 23. Review.

PMID:
20359812
3.

Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.

Tostain J, Li G, Gentil-Perret A, Gigante M.

Eur J Cancer. 2010 Dec;46(18):3141-8. doi: 10.1016/j.ejca.2010.07.020. Epub 2010 Aug 13. Review.

PMID:
20709527
4.

Current status and future directions of molecular markers in renal cell carcinoma.

Rini BI.

Curr Opin Urol. 2006 Sep;16(5):332-6. Review.

PMID:
16905977
5.

Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.

Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA.

Clin Cancer Res. 2003 Oct 15;9(13):4641-52. Review.

6.

Carbonic anhydrase IX: historical and future perspectives.

Oosterwijk E.

BJU Int. 2008 Jun;101 Suppl 4:2-7. doi: 10.1111/j.1464-410X.2008.07641.x. Review. No abstract available.

PMID:
18430115
7.

Biomarker discovery in urogenital cancer.

Said J.

Biomarkers. 2005 Nov;10 Suppl 1:S83-6. Review.

PMID:
16298916
8.

Prognostic and predictive biomarkers in renal cell carcinoma.

Vickers MM, Heng DY.

Target Oncol. 2010 Jun;5(2):85-94. doi: 10.1007/s11523-010-0143-8. Epub 2010 Jun 28. Review.

PMID:
20582732
9.

Carbonic anhydrase expression in kidney and renal cancer: implications for diagnosis and treatment.

Oosterwijk E.

Subcell Biochem. 2014;75:181-98. doi: 10.1007/978-94-007-7359-2_10. Review.

PMID:
24146380
10.

Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.

Tafreshi NK, Lloyd MC, Bui MM, Gillies RJ, Morse DL.

Subcell Biochem. 2014;75:221-54. doi: 10.1007/978-94-007-7359-2_12. Review.

11.

The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.

Sangoi AR, Karamchandani J, Kim J, Pai RK, McKenney JK.

Adv Anat Pathol. 2010 Nov;17(6):377-93. doi: 10.1097/PAP.0b013e3181f89400. Review.

PMID:
20966644
12.

Recent developments in targeting carbonic anhydrase IX for cancer therapeutics.

McDonald PC, Winum JY, Supuran CT, Dedhar S.

Oncotarget. 2012 Jan;3(1):84-97. Review.

13.

Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.

Potter CP, Harris AL.

Br J Cancer. 2003 Jul 7;89(1):2-7. Review.

14.

Targeting carbonic anhydrase IX with small organic ligands.

Wichert M, Krall N.

Curr Opin Chem Biol. 2015 Jun;26:48-54. doi: 10.1016/j.cbpa.2015.02.005. Epub 2015 Feb 24. Review.

PMID:
25721398
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk